|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Methyl isobutyl carbinol | CAS 108-11-2 | ||
| (CH3)2CHCH2CH(OH)CH3 | RTECS SA7350000 | ||
|
Synonyms & Trade Names Isobutylmethylcarbinol, Methyl amyl alcohol, 4-Methyl-2-pentanol, MIBC |
DOT ID & Guide 2053 129 |
||
|
Exposure Limits |
NIOSH REL: TWA 25 ppm (100 mg/m3) ST 40 ppm (165 mg/m3) [skin] | ||
| OSHA PEL�: TWA 25 ppm (100 mg/m3) [skin] | |||
| IDLH 400 ppm | Conversion 1 ppm = 4.18 mg/m3 | ||
|
Physical Description Colorless liquid with a mild odor. |
|||
|
MW: 102.2 |
BP: 271°F |
FRZ: -130°F |
Sol: 2% |
|
VP: 3 mmHg |
IP: ? |
|
Sp.Gr: 0.81 |
|
Fl.P: 106°F |
UEL: 5.5% |
LEL: 1.0% |
|
| Class II Combustible Liquid: Fl.P. at or above 100�F and below 140�F. | |||
|
Incompatibilities & Reactivities Strong oxidizers |
|||
|
Measurement Methods NIOSH 1402; OSHA 7 |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: No recommendation |
First Aid (See procedures) Eye: Irrigate immediately Skin: Water flush promptly Breathing: Respiratory support Swallow: Medical attention immediately |
|
Respirator Recommendations
NIOSH/OSHA Up to 250 ppm: (APF = 10) Any supplied-air respirator* Up to 400 ppm: (APF = 25) Any supplied-air respirator operated in a continuous-flow mode*/(APF = 50) Any self-contained breathing apparatus with a full facepiece/(APF = 50) Any supplied-air respirator with a full facepiece Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Irritation eyes, skin; headache, drowsiness; dermatitis; in animals: narcosis | |
|
Target Organs
Eyes, skin, central nervous system |
|
| See also: INTRODUCTION |